{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:09:07Z","timestamp":1789895347050,"version":"4.0.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Pompe disease, or glycogen storage disease type II, is a rare autosomal recessive disorder caused by mutations in the gene that encodes for \u03b1-glucosidase. Presentation in infancy is associated with respiratory failure, cardiomyopathy, and severe muscle weakness. Juvenile- or adult-onset cases typically present with proximal muscle weakness and are associated with respiratory insufficiency or exertional dyspnea. Treatment, until recently, was focused on supportive measures, and infants diagnosed with Pompe disease usually died within the first year of life. The recent development of recombinant \u03b1-glucosidase has dramatically improved the life expectancy and quality of life of infantile-onset disease with improvements in respiratory and motor function observed in juvenile- or adult-onset cases. This review focuses on the presentation, pathogenesis, diagnosis, and treatment recommendations for Pompe disease in this new era of enzyme replacement therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0b013e318176dbe4","type":"journal-article","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T07:06:51Z","timestamp":1212131211000},"page":"421-431","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":61,"title":["Pompe Disease: A Review of the Current Diagnosis and Treatment Recommendations in the Era of Enzyme Replacement Therapy"],"prefix":"10.1097","volume":"9","author":[{"given":"Lara W","family":"Katzin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240808","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1357-4310(00)01694-4","article-title":"Towards a molecular therapy for glycogen storage disease type II (Pompe disease).","volume":"6","author":"Chen","year":"2000","journal-title":"Mol Med Today"},{"key":"R2-7-20240808","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands; implications for diagnosis and genetics counseling.","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"R3-7-20240808","first-page":"272A","article-title":"Increased frequency of Pompe disease (infantile onset glycogen storage disease type II) in Afro-Americans.","volume":"55","author":"Hirschhorn","year":"2004","journal-title":"Pediatr Res"},{"key":"R4-7-20240808","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01799482","article-title":"Pompes disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity.","volume":"10","author":"Lin","year":"1987","journal-title":"J Inherit Metab Dis"},{"key":"R5-7-20240808","first-page":"91","article-title":"Glycogen storage disease type II: birth prevalence agrees with predicted genotype frequency.","volume":"2","author":"Ausems","year":"1999","journal-title":"Community Genet"},{"key":"R6-7-20240808","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"R8-7-20240808","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompes disease; a review of 225 published cases.","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"R9-7-20240808","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nmd.2006.02.001","article-title":"Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome.","volume":"16","author":"Kostera-Pruszczyk","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"R10-7-20240808","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients.","volume":"17","author":"Muller-Felber","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"R11-7-20240808","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompes disease in 54 Dutch patients.","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"R12-7-20240808","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult onset acid maltase deficiency in France: genotype-phenotype correlation.","volume":"55","author":"Laforet","year":"2007","journal-title":"Neurology"},{"key":"R13-7-20240808","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880160614","article-title":"Adult acid maltase deficiency.","volume":"6","author":"Barohn","year":"1993","journal-title":"Muscle Nerve"},{"key":"R14-7-20240808","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00415-006-0434-2","article-title":"Fatigue: an important feature of late-onset Pompe disease.","volume":"254","author":"Hagemans","year":"2007","journal-title":"J Neurol"},{"key":"R15-7-20240808","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.57.7.1290","article-title":"Sleep-disordered breathing and respiratory failure in acid maltase deficiency.","volume":"57","author":"Mellies","year":"2001","journal-title":"Neurology"},{"key":"R16-7-20240808","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration.","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"R17-7-20240808","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0002-8703(78)90093-5","article-title":"Pompes disease presenting as hypertrophic mycardiopathy with Wolff-Parkinson-White syndrome.","volume":"96","author":"Bulkley","year":"1978","journal-title":"Am Heart J"},{"key":"R18-7-20240808","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.gim.0000217786.79173.a8","article-title":"Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha glucosidase enzyme replacement therapy for Pompe disease.","volume":"8","author":"Cook","year":"2006","journal-title":"Genet Med"},{"key":"R19-7-20240808","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/01.wnl.0000198776.53007.2c","article-title":"Course of disability and respiratory function in untreated late-onset Pompe disease.","volume":"66","author":"Hagemans","year":"2006","journal-title":"Neurology"},{"key":"R20-7-20240808","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/dna.1991.10.283","article-title":"Isolation and partial characterization of the structural gene for human acid alpha glucosidase.","volume":"10","author":"Martiniuk","year":"1991","journal-title":"DNA Cell Biol"},{"key":"R21-7-20240808","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj2720493","article-title":"Characterization of the human lysosomal alpha-glucosidase gene.","volume":"272","author":"Hoefsloot","year":"1990","journal-title":"Biochem J"},{"key":"R22-7-20240808","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mus.880010105","article-title":"Adult onset acid maltase deficiency. A postmortem study.","volume":"1","author":"DiMauro","year":"1978","journal-title":"Muscle Nerve"},{"key":"R23-7-20240808","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/01.wnl.0000299892.81127.8e","article-title":"Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency.","volume":"70","author":"Nascimbeni","year":"2008","journal-title":"Neurology"},{"key":"R24-7-20240808","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","article-title":"Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-G) mutation in a majority of patients and a novel IVS10 (+GT-CT) mutation.","volume":"3","author":"Huie","year":"1994","journal-title":"Hum Mol Genet"},{"key":"R25-7-20240808","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/hmg\/5.7.995","article-title":"A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II).","volume":"5","author":"Raben","year":"1996","journal-title":"Hum Mol Genet"},{"key":"R26-7-20240808","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T-G haplotype.","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"key":"R27-7-20240808","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.20807","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease.","volume":"59","author":"Fukuda","year":"2006","journal-title":"Ann Neurol"},{"key":"R28-7-20240808","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","article-title":"Adult-onset glycogen storage disease type 2: clinic-pathological phenotype revisited.","volume":"33","author":"Schoser","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R29-7-20240808","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol Ther"},{"key":"R30-7-20240808","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jbiomech.2004.05.040","article-title":"Effects of non-contractile inclusions on mechanical performance of skeletal muscle.","volume":"38","author":"Drost","year":"2005","journal-title":"J Biomech"},{"key":"R31-7-20240808","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1651-2227.2006.tb02395.x","article-title":"Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles.","volume":"95","author":"Reuser","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"R32-7-20240808","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00687878","article-title":"Pompes disease: an inborn lysosomal disorder with storage of glycogen.","volume":"23","author":"Martin","year":"1973","journal-title":"Acta Neuropath"},{"key":"R33-7-20240808","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children.","volume":"144","author":"Kishnani","year":"2004","journal-title":"J Pediatr"},{"key":"R34-7-20240808","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation.","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"R35-7-20240808","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline.","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"issue":"1-2","key":"R36-7-20240808","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin Chim Acta"},{"key":"R37-7-20240808","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/clinchem\/47.8.1378","article-title":"Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease.","volume":"47","author":"Umapathysivam","year":"2001","journal-title":"Clin Chem"},{"key":"R38-7-20240808","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2006.12.006","article-title":"Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.","volume":"90","author":"Kallwass","year":"2007","journal-title":"Mol Genet Metab"},{"key":"R41-7-20240808","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid -glucosidase. Major clinical benefits in infantile-onset Pompe disease.","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"R42-7-20240808","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/1363849031000139298","article-title":"Development of a disease-specific disability instrument for Pompe disease.","volume":"6","author":"Haley","year":"2003","journal-title":"Pediatr Rehabil"},{"key":"R43-7-20240808","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","article-title":"Enzyme replacement therapy in late-onset Pompes disease: a three-year follow-up.","volume":"55","author":"Winkel","year":"2004","journal-title":"Ann Neurol"},{"key":"R45-7-20240808","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/01.wnl.0000253226.13795.40","article-title":"Enzyme replacement for infantile Pompe disease. The first step toward a cure.","volume":"68","author":"Wagner","year":"2007","journal-title":"Neurology"},{"key":"R48-7-20240808","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","article-title":"Physical therapy management of Pompe disease.","volume":"8","author":"Case","year":"2006","journal-title":"Genet Med"},{"key":"R49-7-20240808","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1097\/00002060-200211001-00019","article-title":"Role of physical activity and exercise training in neuromuscular disease.","volume":"81","author":"Fowler","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"R50-7-20240808","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1047-9651(18)30286-9","article-title":"Limb contractures in progressive neuromuscular disease and the role of stretching, orthotics, and surgery.","volume":"9","author":"McDonald","year":"1998","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"R51-7-20240808","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/WNL.33.1.34","article-title":"Improvement of muscle function in acid maltase deficiency by high-protein therapy.","volume":"33","author":"Slonim","year":"1983","journal-title":"Neurology"},{"key":"R52-7-20240808","first-page":"328","article-title":"Acid maltase deficiency in an adult. Evidence for improvement in respiratory function with high-protein dietary therapy.","volume":"134","author":"Margolis","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"R53-7-20240808","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20665","article-title":"Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy.","volume":"35","author":"Slonim","year":"2007","journal-title":"Muscle Nerve"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00131402-200806000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T23:20:27Z","timestamp":1723159227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-200806000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0b013e318176dbe4","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}